All the latest worldwide HIV and AIDS news, including treatment, prevention, and hepatitis and TB co-infections. News from our own team of writers plus articles we have selected from other sources.

aidsmap hiv & aids news


← First12345...792Next →

hiv & aids news selected from other sources

  • PrEP
    PrEP uses contributes to decline in STI incidence among MSM
    Healio | 20 February 2017

    Results from a modeling study presented at the Conference on Retroviruses and Opportunistic Infections (CROI) 2017 indicated that the use of pre-exposure prophylaxis for HIV prevention in addition to routine screening and treatment of sexually transmitted infections, or STIs, could reduce the incidence of STIs among men who have sex with men, even when condom use was reduced.

  • Cardiovascular disease
    Darunavir Associated with Heart Disease
    MedPage Today HIV/AIDS | 20 February 2017

    But atazanavir use in HIV patients not linked to cardiovascular disease.

  • Ageing and HIV
    UK’s first LGBT older person’s community planned for Manchester
    Manchester City Council | 19 February 2017

    The ambition to create a community aimed at older lesbian, gay, bisexual and transgender (LGBT) people has been announced today by Manchester City Council.

  • Structural factors
    Rape drives HIV and depression
    Health-e | 19 February 2017

    Sexual violence plays a significant role in HIV infection and depression, according to ground-breaking research with women living in Rustenburg.

  • Neurological and cognitive problems
    No evidence of accelerated brain ageing in HIV positive people on effective ART
    HIV i-Base | 19 February 2017

    A European study reported no evidence of accelerating brain ageing in HIV positive people in ART, based on highly sensitive brain imaging scans and cognitive testing over two year.

  • Pharmaceutical industry
    Merck's lead HIV play hits the mark in first phase 3 challenge
    FierceBiotech | 19 February 2017

    Merck has taken a big step toward getting its lead HIV candidate doravirine to market, setting up a showdown with Johnson & Johnson's big-selling Prezista.

  • Global health initiatives
    A Contentious List of Finalists for Global Aid Fund Group’s Director
    New York Times | 19 February 2017

    Three candidates to become the next director of the Global Fund to Fight AIDS, Tuberculosis and Malaria are likely to draw harsh scrutiny from the fund’s largest donor, the United States.

  • Clinical trials
    Vaccine trial: Community trust is key
    Fred Hutch | 17 February 2017

    Dr. Linda-Gail Bekker knows from more than 20 years in the field that researchers have to work hand in hand with the communities most affected if they want to halt an epidemic. And the townships are ground zero for HIV/AIDS in Cape Town.

  • PrEP
    Oral PrEP Works Well in Women With Abnormal Vaginal Microbiota
    Poz | 16 February 2017

    This challenges a finding that an anti-HIV vaginal gel might not be effective in women with abnormal vaginal flora.

  • HIV prevention policy
    An 18% Decline in HIV Incidence in the US Over Six Years is Not Enough
    Huffington Post | 16 February 2017

    David Holtgrave and Robert Bonacci: "At a time when some decision makers are considering possibly repealing and/or replacing the Affordable Care Act, which we know provided critical health insurance access for persons living with HIV and helped to avoid HIV transmission, we should instead be focusing as a nation on expanding critical HIV-related services and access to comprehensive care."

← First12345...1285Next →

Conference news

News from the Conference on Retroviruses and Opportunistic Infections (CROI 2017).

HIV update

Sign up for HIV update, our fortnightly news bulletin for people living with HIV in the UK.

Achieving the 90-90-90 target

With advances in HIV testing, treatment and care, some countries are making great progress towards the UNAIDS 90-90-90 target.

aidsmap news apps

Download the free aidsmap news iPhone and android apps.

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.